BioSpace News Archive

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brian M. Culley, Chief Executive Officer, will be presenting at the 2020 Solebury Trout Virtual Investor Conference on May 26, 2020 at 2:30 pm Eastern Time. Interested investors can access the live presentation as part of the Solebury Trout

Orexo, a Swedih pharmaceutical company focused on improved pharmaceuticals and digital therapies, announced that it will partner with Lyfebulb, a patient empowerment platform, to work with substance abuse patients to identify unmet needs made more acute by the pandemic,

Phase II clinical trial expected to be conducted at multiple centers in the United States, including three Mayo Clinic sites under the leadership of Andrew D. Badley, M.D., Enterprise Chair of COVID-19 Task Force Randomized, double blind, placebo-controlled clinical trial to be conducted in adults with COVID-19 who are hospitalized and either require supplemental oxygen or are on non-invasive ventilation or high flow oxygen devices BioS

Blue Earth Diagnostics Announces Results from Early Clinical Experience with Targeted PET Imaging Agent rhPSMA-7.3 ( 18 F) in Men with Intermediate and High-risk Prostate Cancer − Results related to Company’s investigational Phase 3 radiohybrid PSMA agent presented at the AUA2020 Virtual Meeting − BURLINGTON, Mass. & OXFORD, England--( BUSINESS WIRE )-- Blue Earth Diagnostics, a Bracco company focused on molecular imaging diagnostics, today announc

SEC Order found Li and 1Globe Violated SEC Rules and Federal Securities Laws by Failing to Disclose Key Facts regarding their Holdings of Sinovac BEIJING--( BUSINESS WIRE )-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced that the United States Securities and Exchange Commission (“SEC”) charged activist investor, Jiaqiang “Chiang” Li and his firm 1Globe Capital LLC (

Continued annual revenue growth Number of commercial CDA (cancer differentiation analysis)-based tests increased 26.0% year-on-year Continued to gain customers and increase the acceptance of our cancer risk assessment tests SAN JOSE, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio,” “we” or the “Company”), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced

Emmes today announced that it was ranked as the seventh largest biosciences employer in the greater Washington area. The ranking is compiled annually by the Washington Business Journal.

Harmonic Bionics, Inc. announced that they will be hosting live virtual demos of the company’s new upper body robotic rehabilitation system, Harmony SHR.

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid Restart™ program. Launched over a month ago, Taconic was the first animal model provider in the industry to provide researchers with a program specifically designed to aid laboratories transitioning back to increased productivity. COVID-19 forced many institutions to discontinue critical research prog

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced today its oncology-focused subsidiary, Sapphire Biotech, Inc. (“Sapphire”), filed a utility patent application relating to a novel biomarker for the detection of cancer in blood serum and urine. “Sapphire’s diagnostics products have the potential to chang